I have diabetes. Can postmenopause make sugar control harder?

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Your HbA1c (glycated hemoglobin) of 7.9 shows that while Metformin and lifestyle changes are helping, your diabetes is not fully controlled, and at this stage, many doctors would consider adding a second medication.

Both SGLT2 (sodium-glucose co-transporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists are excellent next steps, and the choice often depends on your overall health profile and goals.

SGLT2 inhibitors (like Empagliflozin or Dapagliflozin) work through the kidneys to lower blood sugar and also provide heart and kidney protection, which is especially valuable if cardiovascular or kidney risks are present.

GLP-1 receptor agonists (like Semaglutide or Dulaglutide) lower blood sugar, aid in weight loss, and also reduce heart risk, but they are usually injected (though oral options now exist).

Since your kidney function and blood pressure are normal, either option could be considered, and doctors often decide based on whether weight loss, heart protection, or convenience is the highest priority.

For home glucose checks, fasting blood sugar levels in the morning and post-meal readings (usually two hours after eating) are the most useful for guiding adjustments, as fasting reflects overnight liver glucose output and post-meal spikes indicate how well meals and medications are being managed.

Menopause can also make sugar control more difficult, as declining estrogen levels worsen insulin resistance and affect fat distribution, meaning that even with a good diet and activity, sugars may rise more easily.

In your case, adding another medication alongside your healthy habits should help bring your HbA1c closer to target and reduce long-term risks.

I hope this helps.

Thank you and take care.

Regards.